Gryphon Financial Partners LLC Abbott Laboratories Transaction History

Gryphon Financial Partners LLC

  • $736 Million
  • Q3 2024

A detailed history of Gryphon Financial Partners LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Gryphon Financial Partners LLC holds 113,876 shares of ABT stock, worth $13.2 Million. This represents 1.76% of its overall portfolio holdings.

Number of Shares
113,876
Previous 113,620 0.23%
Holding current value
$13.2 Million
Previous $11.8 Million 9.97%
% of portfolio
1.76%
Previous 1.78%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$100.07 - $118.13 $25,617 - $30,241
256 Added 0.23%
113,876 $13 Million
Q2 2024

Aug 07, 2024
BUY
$100.73 - $112.44 $221,001 - $246,693
2,194 Added 1.97%
113,620 $11.8 Million
Q1 2024

May 01, 2024
BUY
$109.52 - $120.96 $27,380 - $30,240
250 Added 0.22%
111,426 $12.7 Million
Q4 2023

Feb 06, 2024
BUY
$90.19 - $110.4 $339,745 - $415,876
3,767 Added 3.51%
111,176 $12.2 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $178,450 - $214,110
-1,868 Reduced 1.71%
107,409 $10.4 Million
Q2 2023

Aug 08, 2023
BUY
$100.78 - $112.29 $45,653 - $50,867
453 Added 0.42%
109,277 $11.9 Million
Q1 2023

May 03, 2023
SELL
$96.86 - $114.01 $3,390 - $3,990
-35 Reduced 0.03%
108,824 $11 Million
Q4 2022

Feb 08, 2023
SELL
$95.06 - $111.52 $23,955 - $28,103
-252 Reduced 0.23%
108,859 $12 Million
Q3 2022

Nov 14, 2022
BUY
$96.76 - $112.03 $178,618 - $206,807
1,846 Added 1.72%
109,111 $10.6 Million
Q2 2022

Jul 28, 2022
BUY
$102.07 - $123.37 $87,984 - $106,344
862 Added 0.81%
107,265 $11.7 Million
Q1 2022

May 05, 2022
BUY
$114.02 - $139.04 $73,428 - $89,541
644 Added 0.61%
106,403 $12.6 Million
Q4 2021

Feb 01, 2022
SELL
$115.53 - $141.46 $20,910 - $25,604
-181 Reduced 0.17%
105,759 $14.9 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $144,658 - $160,034
1,240 Added 1.18%
105,940 $12.5 Million
Q2 2021

Aug 13, 2021
SELL
$105.79 - $124.53 $138,584 - $163,134
-1,310 Reduced 1.24%
104,700 $12.1 Million
Q1 2021

May 05, 2021
BUY
$108.84 - $128.23 $3.02 Million - $3.56 Million
27,761 Added 35.48%
106,010 $12.7 Million
Q4 2020

Feb 10, 2021
BUY
$105.0 - $114.42 $68,250 - $74,373
650 Added 0.84%
78,249 $8.57 Million
Q3 2020

Nov 16, 2020
SELL
$91.64 - $111.29 $277,577 - $337,097
-3,029 Reduced 3.76%
77,599 $8.45 Million
Q2 2020

Aug 13, 2020
SELL
$76.57 - $98.0 $148,775 - $190,414
-1,943 Reduced 2.35%
80,628 $7.37 Million
Q1 2020

May 05, 2020
SELL
$62.82 - $91.86 $132,738 - $194,100
-2,113 Reduced 2.5%
82,571 $6.52 Million
Q4 2019

Feb 06, 2020
SELL
$78.51 - $87.4 $32,503 - $36,183
-414 Reduced 0.49%
84,684 $7.36 Million
Q3 2019

Nov 07, 2019
SELL
$81.84 - $88.74 $16,368 - $17,748
-200 Reduced 0.23%
85,098 $7.12 Million
Q2 2019

Aug 09, 2019
BUY
$72.88 - $85.0 $118,211 - $137,870
1,622 Added 1.94%
85,298 $7.17 Million
Q1 2019

May 07, 2019
SELL
$66.22 - $80.06 $109,792 - $132,739
-1,658 Reduced 1.94%
83,676 $6.69 Million
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $66,805 - $75,681
-1,019 Reduced 1.18%
85,334 $6.17 Million
Q3 2018

Nov 06, 2018
BUY
$60.81 - $73.36 $109,214 - $131,754
1,796 Added 2.12%
86,353 $6.34 Million
Q2 2018

Aug 14, 2018
SELL
$57.57 - $63.54 $2,590 - $2,859
-45 Reduced 0.05%
84,557 $5.16 Million
Q1 2018

May 14, 2018
SELL
$56.27 - $63.62 $52,049 - $58,848
-925 Reduced 1.08%
84,602 $5.07 Million
Q4 2017

Feb 09, 2018
BUY
$53.68 - $57.47 $4.59 Million - $4.92 Million
85,527
85,527 $4.88 Million

Others Institutions Holding ABT

# of Institutions
3,187
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Gryphon Financial Partners LLC Portfolio

Follow Gryphon Financial Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gryphon Financial Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email